Search

Search Constraints

You searched for: Author/Creator Lee, Eddie B.

Search Results

1. A consensus proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation: Molecular and cell biology/others. (7th December 2020)

2. ATN classifications in a mixed cohort of frontotemporal lobar degeneration (FTLD) and Alzheimer's disease (AD) pathology using cerebrospinal fluid neurofilament light chain (NFL): Biomarkers (non‐neuroimaging) / Differential diagnosis. (7th December 2020)

3. Automatic analysis and validation of digitized speech markers in Lewy body spectrum diseases with Alzheimer's disease co‐pathology. (1st February 2022)

4. Automatic analysis and validation of digitized speech markers in Lewy body spectrum diseases with Alzheimer's disease co‐pathology. (December 2021)

5. Calsyntenin‐1 is a cerebrospinal fluid marker of frontotemporal dementia‐related synapse degeneration. (31st December 2021)

7. High‐resolution postmortem MRI reveals TDP‐43 association with medial temporal lobe subregional atrophy: Biomarkers: Leveraging postmortem collections to validate neuroimaging. (7th December 2020)

8. IC‐P‐043: CONTRIBUTION OF TAU, TDP‐43, β‐AMYLOID AND α‐SYNUCLEIN TO MEDIAL TEMPORAL LOBE ATROPHY. (1st July 2019)

9. Novel ex vivo MRI atlas of the medial temporal lobe can be used to characterize structural changes due to Alzheimer's disease pathology: Neuroimaging: The medial temporal lobe in 2020. (7th December 2020)

10. O2‐08‐05: PATHOLOGICAL DRIVERS OF NEURODEGENERATION IN SUSPECTED NON‐ALZHEIMER'S PATHOPHYSIOLOGY. (1st July 2019)